Impact Factor 3.508

Frontiers journals are at the top of citation and impact metrics

Original Research ARTICLE Provisionally accepted The full-text will be published soon. Notify me

Front. Neurol. | doi: 10.3389/fneur.2018.01121

Direct Bypass surgery versus Combined Bypass surgery for Hemorrhagic Moyamoya Disease: A Comparison of Angiographic Outcomes

 Yahui Zhao1, Shaochen Yu1, Junlin Lu1, Jiaxi Li1, Yan Zhang1,  Dong Zhang1, Rong Wang1 and  Yuanli Zhao1*
  • 1Beijing Tiantan Hospital, Capital Medical University, China

Objective: Extracranial-intracranial bypass is currently recognized as the optimal treatment for hemorrhagic-type moyamoya disease (MMD) which reduces incidence of rebleeding. Recent studies have reported the advantage of combined bypass over direct bypass for the general MMD patients, however, the effect of direct bypass and combined bypass surgery specifically for hemorrhagic-type MMD had not been investigated yet.
Methods: Hemorrhagic-type MMD patients who underwent direct and combined bypass surgery with complete clinical and radiological documentation from a multicenter cohort between 2009 and 2017 were retrospectively included. Surgical methods included superficial temporal artery-middle cerebral artery (STA-MCA) anastomosis (direct bypass), combined STA-MCA bypass with encephalodurosynangiosis (EDS), and combined STA-MCA bypass with encephaloduroarteriosynangiosis (EDAS). Matsushima standard on follow-up catheter angiography was used to assess surgical outcome. Modified Rankin Scale, incidence of rebleeding and ischemia during follow-up were recorded. Rebleeding-free survival rates between direct and combined bypass were compared by Kaplan-Meier analysis.
Results: Sixty-eight hemorrhagic-onset MMD patients were included in this study and among which 71 hemispheres were treated with surgery (direct bypass: 17; bypass+EDS:24; bypass+EDAS: 30). Forty-six (64.8%) hemispheres had satisfactory revascularization (Matsushima level 2-3) and 26 (36.6%) had poor neoangiogenesis. Matsushima level was not significantly different between surgical groups (P=0.258). Good neoangiogenesis from dural grafts was achieved in 26 (36.6%) hemispheres, and good neoangiogenesis from STA grafts was only seen in 4 (out of 30, 12.5%) hemispheres. Multivariate analysis showed bypass patency (P<0.001, OR(95%CI): 13.41 (3.28-54.80)) and dural neoangiogenesis (P<0.001, OR(95%CI): 13.18 (3.26-53.36)) both independently contributed good angiographic outcome. During follow-up, incidences of rebleeding or ischemic events, and re-bleeding free survival rate were not significantly different between surgical groups (P=0.433, P=0.559 and P=0.997). However, patients underwent combined bypass surgery had significantly lower mRS at follow-up comparing to patients underwent direct bypass (P=0.006).
Conclusion: Combined bypass surgery and direct bypass surgery offered similar revascularization for hemorrhagic MMD. Bypass patency and dural angiogenesis both contributed to revascularization independently. The potential of indirect bypass to grow new vessels in hemorrhagic-MMD patients was generally limited, but dural leaflets offered better neoangiogenesis than STA grafts and was therefore recommended for surgical revascularization of hemorrhagic MMD.

Keywords: Moyamoya disease (MMD), hemorrhagic-type, Surgical revascularization, Direct bypass, combined bypass, angiographic outcomes, surgical outcome

Received: 06 Aug 2018; Accepted: 06 Dec 2018.

Edited by:

Emmanuel Carrera, Faculté de médecine, Université de Genève, Switzerland

Reviewed by:

Diogo C. Haussen, Emory University, United States
Luca Regli, University of Zurich, Switzerland  

Copyright: © 2018 Zhao, Yu, Lu, Li, Zhang, Zhang, Wang and Zhao. This is an open-access article distributed under the terms of the Creative Commons Attribution License (CC BY). The use, distribution or reproduction in other forums is permitted, provided the original author(s) and the copyright owner(s) are credited and that the original publication in this journal is cited, in accordance with accepted academic practice. No use, distribution or reproduction is permitted which does not comply with these terms.

* Correspondence: Dr. Yuanli Zhao, Beijing Tiantan Hospital, Capital Medical University, Beijing, China,